Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d160aeee278e57d6e251c4a98a19b0e6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate |
2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c297cdd9e024ca4b48dfccfd3e409db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a64b65c0266ef77ee52a0e8fcc06c76 |
publicationDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10596186-B2 |
titleOfInvention |
Method and compositions for treating viral infections |
abstract |
A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae, Flaviviridae or Togaviriade family, is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021201903-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023022866-A1 |
priorityDate |
2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |